Template:Drug List/ja: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(15 intermediate revisions by the same user not shown) | |||
Line 24: | Line 24: | ||
}} | }} | ||
<!-------------------------- | <!-------------------------- | ||
| group2 = [[Human brain/ja|脳]]・[[nervous system/ja|神経系]] | | group2 = [[Human brain/ja|脳]]・[[nervous system/ja|神経系]] | ||
| abbr2 = brain & nervous | | abbr2 = brain & nervous | ||
| list2 = | | list2 = | ||
-----------> | |||
<!------------------------- | |||
<!------------------------- | |||
| group3 = [[respiratory system/ja|呼吸器系]] | | group3 = [[respiratory system/ja|呼吸器系]] | ||
| abbr3 = respiratory | | abbr3 = respiratory | ||
| list3 = | | list3 = | ||
------------> | |||
<!-------------------------------------> | <!-------------------------------------> | ||
Line 45: | Line 45: | ||
| abbr5 = gastrointestinal | | abbr5 = gastrointestinal | ||
| list5 = | | list5 = | ||
{{Navbox|subgroup | |||
|group1=[[Antidiarrheal/ja|止瀉薬]] | |||
|list1=[[Probiotics/ja|プロバイオティクス]] | |||
}} | |||
<!-------------------------------------> | <!-------------------------------------> | ||
Line 50: | Line 54: | ||
| abbr6 = endocrine | | abbr6 = endocrine | ||
| list6 = | | list6 = | ||
{{Navbox|subgroup | |||
|group1=[[Diabetes medication/ja|糖尿病治療薬]] | |||
|list1={{Navbox|child | |||
|group1=[[Insulin/ja|インスリン]]/[[insulin analog/ja|インスリンアナログ]] | |||
|list1= | |||
* 超速効型 | |||
** [[Insulin aspart/ja]] | |||
** [[Insulin lispro/ja]] | |||
** [[Insulin glulisine/ja]] | |||
* 速効型 | |||
** [[Regular insulin/ja]] | |||
* 中間型 | |||
** [[NPH insulin/ja]] | |||
* 持効型 | |||
** [[Insulin degludec/ja]] | |||
** [[Insulin detemir/ja]] | |||
** [[Insulin glargine/ja]] | |||
|group2=非インスリン | |||
|list2={{Navbox|child | |||
|group1=[[Anti-diabetic medication#Sensitizers/ja|インスリン感作薬]] | |||
|list1= | |||
* [[Biguanide/ja]] | |||
* [[Thiazolidinedione/ja|TZD]]/"グリタゾン" ([[PPAR agonist/ja|PPAR]]) | |||
* [[PPAR agonist/ja#Dual PPAR agonists|デュアルPPAR作動薬]] | |||
* [[Amylin/ja]]アナログと[[DACRA/ja|DACRA]] | |||
|group2=[[Anti-diabetic medication/ja#Secretagogues|セクレタゴーグ]] | |||
|list2= | |||
* [[ATP-sensitive potassium channel/ja|K<sup>+</sup><sub>ATP</sub>]] | |||
** [[Sulfonylurea/ja]] | |||
** [[Meglitinide/ja]]/"グリニド系" | |||
* [[Gliflozin/ja|SGLT2 阻害薬]]/"グリフロジン" | |||
* [[Glucagon-like peptide-1 receptor agonist/ja|GLP-1受容体作動薬]] | |||
* [[Dipeptidyl peptidase-4 inhibitor/ja|DPP-4 阻害薬]]/"グリプチン" | |||
* [[Aldose reductase inhibitor/ja]] | |||
* [[Alpha-glucosidase inhibitor/ja]] | |||
* その他 | |||
** [[Benfluorex/ja]]<sup>‡</sup> | |||
** [[Bromocriptine/ja]] | |||
** [[Imeglimin/ja]] | |||
|group3=配合薬 | |||
|list3=配合薬 | |||
}} | |||
}} | |||
|group2=[[Lipid-lowering agent/ja|脂質異常症治療薬]] | |||
|list2={{Navbox|child | |||
|group1=スタチン | |||
|list1= | |||
|group2=フィブラート | |||
|list2= | |||
|group3=その他 | |||
|list3= | |||
*EPA製剤 | |||
**[[Omega-3 acid ethyl esters/ja|オメガ3酸エチルエステル]] | |||
**[[Ethyl eicosapentaenoic acid/ja|エイコサペンタエン酸エチル]] | |||
}} | |||
}} | |||
<!-------------------------------------> | <!-------------------------------------> | ||
| group7 = [[genitourinary system/ja|泌尿器・生殖器系]] | | group7 = [[genitourinary system/ja|泌尿器・生殖器系]] | ||
| abbr7 = genitourinary | | abbr7 = genitourinary | ||
| list7 = | | list7 = | ||
{{Navbox|subgroup | |||
|group1=[[Hyperuricemia/ja|高尿酸血症]] | |||
|list1= | |||
* [[Xanthine oxidase inhibitor/ja|キサンチンオキシダーゼ阻害剤]] | |||
* [[Uricosurics/ja|尿酸排泄促進薬]] | |||
}} | |||
<!--------------------------- | <!--------------------------- | ||
| group8 = [[Sense/ja|感覚器系]] | | group8 = [[Sense/ja|感覚器系]] | ||
| abbr8 = sense | | abbr8 = sense | ||
| list8 = | | list8 = | ||
----------> | |||
<!------------------------------ | <!------------------------------ | ||
| group9 = [[Dentistry drug/ja|歯科用薬]] | | group9 = [[Dentistry drug/ja|歯科用薬]] | ||
| abbr9 = sense | | abbr9 = sense | ||
| list9 = | | list9 = | ||
----------> | |||
<!------------------------ | <!------------------------ | ||
| group10 = [[Vitamin/ja|ビタミン製剤]]・[[Infusion/ja|輸液製剤]] | | group10 = [[Vitamin/ja|ビタミン製剤]]・[[Infusion/ja|輸液製剤]] | ||
| abbr10 = vitamin | | abbr10 = vitamin | ||
| list10 = | | list10 = | ||
-------------> | |||
<!---------------------------- | <!---------------------------- | ||
| group11 = [[Blood product/ja|血液製剤]]・[[Anticoagulants/ja|血液作用薬]] | | group11 = [[Blood product/ja|血液製剤]]・[[Anticoagulants/ja|血液作用薬]] | ||
| abbr11 = blood | | abbr11 = blood | ||
| list11 = | | list11 = | ||
---------> | |||
<!----------------------------- | <!----------------------------- | ||
| group12 = [[Anti-Cancer Drugs/ja|抗悪性腫瘍薬]]・[[Immunosuppressive drug/ja|免疫抑制剤]] | | group12 = [[Anti-Cancer Drugs/ja|抗悪性腫瘍薬]]・[[Immunosuppressive drug/ja|免疫抑制剤]] | ||
| abbr12 = oncology | | abbr12 = oncology | ||
| list12 = | | list12 = | ||
--------> | |||
<!-------------------------------------> | <!-------------------------------------> | ||
Line 133: | Line 203: | ||
|group16=祛湿剤 | |group16=祛湿剤 | ||
|list16= | |list16=* [[真武湯]](30) | ||
|group17=祛痰剤 | |group17=祛痰剤 | ||
Line 154: | Line 224: | ||
}} | }} | ||
<!-------------------------- | <!-------------------------- | ||
| group14 = その他 | | group14 = その他 | ||
| abbr14 = etc | | abbr14 = etc | ||
| list14 = | | list14 = | ||
-----------> | |||
| below = | | below = |
Latest revision as of 15:52, 25 April 2024
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Drug List|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Drug List|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Drug List|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.